Brandron Tablet 150mg (Ibandronate Sodium Monohydrate)
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
MFDS item code 201310210 · Approved 2013.11.20
This product's status changed to Expired on 2023.11.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of postmenopausal osteoporosis
This medication is used to treat osteoporosis that may occur in postmenopausal women. It helps to increase bone strength and prevent bone density loss, thereby reducing the risk of fractures. Regular use is effective in improving bone health and preventing fractures that interfere with daily life.
Regularly take 1 tablet once a month on the same day each month, with sufficient water at least 1 hour before eating food, beverages (excluding water), or other oral medications or dietary supplements (including calcium). This medication should be swallowed with a sufficient amount (180-240ml) of water while in an upright or seated position, and lying down for 60 minutes after taking it is prohibited. Mineral water may reduce the absorption of this medication.
The efficacy and safety in children under 18 years of age have not been studied.
This medicine should not be used in certain patients. For example, it should not be administered to patients with an allergy to this medication or its components, or those with untreated low calcium levels. Additionally, patients who cannot sit or stand upright for at least 60 minutes or those with esophageal issues that make swallowing difficult should not take this medication. It contains lactose; hence, it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Care should be taken when administering this medication to patients with severe renal insufficiency. While taking this medication, gastrointestinal disturbances such as dyspepsia, nausea, abdominal pain, diarrhea, headache, muscle pain, joint pain, and rash may occur. Particularly, during the first administration, patients may temporarily experience influenza-like symptoms such as joint pain, muscle pain, fever, chills, and fatigue, which are usually mild and resolve without treatment. This medication may irritate the gastrointestinal mucosa, so if symptoms such as esophagitis or esophageal ulcers, or difficulty swallowing occur, discontinue use immediately and consult a doctor. Furthermore, patients with gastrointestinal disorders should exercise caution when taking this medication. As a bisphosphonate, cases of jaw osteonecrosis or external auditory canal osteonecrosis have been reported rarely, and oral examinations are recommended before dental treatments. It is advisable to avoid excessive dental treatments while taking this medication. Additionally, severe bone, joint, or muscle pain may occur during the course of this medication, and if this happens, patients should consult a doctor. There is also a possibility of atypical fractures occurring in the femur, so any pain in the thigh or groin should be evaluated. This medication may hinder absorption if taken with food, calcium, aluminum, magnesium, iron, etc., so it should be taken with a sufficient amount of water at least one hour prior to consuming food or medications that contain these components. It is safest not to use this medication during pregnancy or breastfeeding. No dosage adjustment is required for older adults, but the safety and effectiveness for children under 18 years have not been established. In cases of overdose, gastrointestinal disturbances or hypocalcemia may appear; do not induce vomiting and maintain an upright position. This medication should be stored out of the reach of children, and unused medication should be disposed of appropriately to prevent environmental contamination.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. In addition, it is best to avoid storing the medication in excessively hot or cold places, keeping it at room temperature between 1 and 30 degrees Celsius.
White to nearly white rectangular film-coated tablet
1 tablet (1 tablet/PTPx1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.